FDA approves immune-boosting therapy for prostate cancer
Friday, April 30, 2010 - 11:03
in Health & Medicine
It marks the agency’s first approval of an immunotherapy treatment for cancer, a move toward a new approach to battling many forms of the disease. The Food and Drug Administration approved a new immune-boosting therapy for prostate cancer on Thursday, the first therapeutic vaccine for cancer ever approved by the agency. The approval opens the door to a whole new approach to cancer...